AR062758A1 - Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor - Google Patents

Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor

Info

Publication number
AR062758A1
AR062758A1 ARP070104028A ARP070104028A AR062758A1 AR 062758 A1 AR062758 A1 AR 062758A1 AR P070104028 A ARP070104028 A AR P070104028A AR P070104028 A ARP070104028 A AR P070104028A AR 062758 A1 AR062758 A1 AR 062758A1
Authority
AR
Argentina
Prior art keywords
heat
leptospira
heat treated
batteries
treated
Prior art date
Application number
ARP070104028A
Other languages
English (en)
Inventor
Mark Davis Goodyear
Michael John Huether
Ramasamy Mannar Mannan
Nances Lois Odien
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR062758A1 publication Critical patent/AR062758A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Se describen bacterinas tratadas con calor, un método para producir bacterinas tratadas con calor y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor. Reivindicacion 7: Una bacterina tratada con calor que comprende una suspension de bacterias muertas de acuerdo con la reivindicacion 2, donde las bacterias muertas son de una a cinco especies de Leptospira seleccionadas entre el grupo compuesto por Leptospira canícola, Leptospira grippofyposa, Leptospira hardjo, Leptospira icterohaemorrhagiae y Leptospira pomona. Reivindicacion 8: Una vacuna que comprende una emulsion y una bacterina tratada con calor de acuerdo con la reivindicacion 2. Reivindicacion 12: Una vacuna de acuerdo con la reivindicacion 9, que comprende además virus muertos.
ARP070104028A 2006-09-11 2007-09-11 Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor AR062758A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84366506P 2006-09-11 2006-09-11

Publications (1)

Publication Number Publication Date
AR062758A1 true AR062758A1 (es) 2008-12-03

Family

ID=39110574

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104028A AR062758A1 (es) 2006-09-11 2007-09-11 Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor

Country Status (27)

Country Link
US (1) US8491915B2 (es)
EP (2) EP2377550B1 (es)
JP (2) JP5550341B2 (es)
KR (1) KR101238486B1 (es)
CN (1) CN101516393B (es)
AR (1) AR062758A1 (es)
AU (1) AU2007297287B2 (es)
BR (1) BRPI0716548B1 (es)
CA (1) CA2663166C (es)
CL (1) CL2007002621A1 (es)
CO (1) CO6160333A2 (es)
DK (2) DK2066340T3 (es)
ES (2) ES2432392T3 (es)
HK (1) HK1130202A1 (es)
ME (1) ME00598B (es)
MX (1) MX2009001849A (es)
NO (1) NO339147B1 (es)
NZ (2) NZ574896A (es)
PL (2) PL2377550T3 (es)
PT (1) PT2066340E (es)
RS (1) RS54981B1 (es)
RU (2) RU2425692C2 (es)
SI (1) SI2066340T1 (es)
TW (1) TWI361077B (es)
UA (1) UA98115C2 (es)
WO (1) WO2008032158A2 (es)
ZA (1) ZA200902493B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009090461A1 (en) * 2007-12-21 2009-07-23 Pfizer Inc. Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
EP2717055A1 (en) * 2012-10-04 2014-04-09 Institut Pasteur Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis
JP2024510057A (ja) * 2020-05-26 2024-03-06 サイラス トェンティファースト センチュリー アントレプレナーシップ エルエルシー ハキムプールシナの除染手順

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721169A1 (de) * 1986-06-30 1988-01-14 Lion Corp Orale zubereitung
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
AU2001234616A1 (en) 2000-01-31 2001-08-07 Vic Jira Vaccine composition, process and methods
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
CA2496750C (en) 2002-08-26 2014-10-21 Pfizer Products Inc. Vaccine for respiratory and reproductive system infections in cattle
EP1549135A4 (en) 2002-09-20 2006-01-11 Us Agriculture VACCINE AND ADJUVANT COMPOSITIONS
AU2002951692A0 (en) 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
KR20050103215A (ko) * 2003-01-29 2005-10-27 화이자 프로덕츠 인코포레이티드 보르데텔라 브론키셉티카에 대한 개 백신
PT1613346E (pt) * 2003-04-04 2013-01-29 Pah Usa 15 Llc Emulsões óleo-em-água microfluidificadas e composições de vacinas

Also Published As

Publication number Publication date
MEP7509A (en) 2011-12-20
US20080112970A1 (en) 2008-05-15
DK2377550T3 (en) 2015-04-07
NZ595748A (en) 2013-07-26
RS54981B1 (sr) 2016-11-30
KR101238486B1 (ko) 2013-03-04
JP2014088428A (ja) 2014-05-15
RU2569457C2 (ru) 2015-11-27
RU2009108004A (ru) 2010-10-20
AU2007297287B2 (en) 2013-03-14
CO6160333A2 (es) 2010-05-20
ES2432392T3 (es) 2013-12-03
ES2535977T3 (es) 2015-05-19
WO2008032158A2 (en) 2008-03-20
SI2066340T1 (sl) 2013-11-29
EP2066340B1 (en) 2013-07-31
RU2425692C2 (ru) 2011-08-10
PT2066340E (pt) 2013-10-30
CL2007002621A1 (es) 2008-03-14
EP2377550B1 (en) 2015-03-04
TWI361077B (en) 2012-04-01
JP5643906B2 (ja) 2014-12-17
KR20090039840A (ko) 2009-04-22
ZA200902493B (en) 2010-03-31
JP5550341B2 (ja) 2014-07-16
CA2663166C (en) 2015-11-03
US8491915B2 (en) 2013-07-23
CN101516393A (zh) 2009-08-26
EP2066340A2 (en) 2009-06-10
DK2066340T3 (da) 2013-10-14
JP2010502238A (ja) 2010-01-28
UA98115C2 (ru) 2012-04-25
NZ574896A (en) 2011-11-25
NO339147B1 (no) 2016-11-14
MX2009001849A (es) 2009-03-02
PL2066340T3 (pl) 2013-12-31
HK1130202A1 (en) 2009-12-24
PL2377550T3 (pl) 2015-07-31
TW200820990A (en) 2008-05-16
EP2377550A1 (en) 2011-10-19
NO20090745L (no) 2009-03-11
CA2663166A1 (en) 2008-03-20
AU2007297287A1 (en) 2008-03-20
ME00598B (me) 2011-12-20
BRPI0716548B1 (pt) 2020-10-06
BRPI0716548A2 (pt) 2013-09-24
CN101516393B (zh) 2014-05-14
RU2011115400A (ru) 2012-10-27
WO2008032158A3 (en) 2008-07-03
RS20090088A (en) 2010-06-30

Similar Documents

Publication Publication Date Title
CL2008003845A1 (es) Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.
BRPI0607551A2 (pt) vacinas de combinação de helicobacter e circovìrus porcino e métodos de uso
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
ECSP066916A (es) Vacuna contra estreptococo agalactiae
IN2014DN08830A (es)
RU2013117079A (ru) Вируса гриппа способ репликации в культуре
WO2008127296A3 (en) Methods and compositions for treating tularemia
CN106075419B (zh) 一种杀鲑气单胞菌灭活疫苗及其应用
CO6260102A2 (es) Cepas de mycoplasma gallisepticum atenuadas
Breard et al. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus
BR112015012711B1 (pt) Método para preparar uma composição imunogênica para o tratamento e/ou a profilaxia de infecções por mycoplasma
PE20140871A1 (es) COMPOSICIONES Y METODOS DE VACUNA DEL VIRUS TIPO 1b DE DIARREA VIRAL BOVINA
AR075484A1 (es) Pestivirus quimericos
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
AR062758A1 (es) Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor
RU2016116988A (ru) Вакцина против haemophilus parasuis серологического типа 4
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
PE20211648A1 (es) Composicion de vacuna combinada que comprende dosis reducidas del virus inactivado de la polio y metodo de preparacion de la misma
RU2006133328A (ru) Способ вакцинации против инфекции семенников bvdv
Patil et al. Virulence pattern of Avibacterium paragallinarum isolates studied from Indian field condition
ES2828873T3 (es) Vacuna contra la disentería porcina
NZ544453A (en) Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird)
Rose et al. Impact de la vaccination sur la transmission du Circovirus porcin de type 2 (PCV‐2)

Legal Events

Date Code Title Description
FC Refusal